-
1 Comment
Kotra Industries Bhd is currently in a long term downtrend where the price is trading 15.9% below its 200 day moving average.
From a valuation standpoint, the stock is 62.6% cheaper than other stocks from the Other sector with a price to sales ratio of 2.4.
Based on the above factors, Kotra Industries Bhd gets an overall score of 1/5.
| ISIN | MYQ0002OO004 |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | KLSE |
| CurrencyCode | MYR |
| Target Price | 5.1 |
|---|---|
| Beta | 0.04 |
| PE Ratio | 15.56 |
| Dividend Yield | 6.1% |
| Market Cap | 623M |
Kotra Industries Berhad, an investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia. The company provides nutraceutical products, including various health supplement products under the Appeton brand for children, expectant mothers, and seniors. It also offers various pharmaceutical products in the areas of pediatric care, anti-infective, gastroenterology, and dermatology under the Axcel brand; sterile antibiotic injectables under the Vaxcel brand; asthma control products under the Arite brand; and fungal infection treatment products under the Creobic brand. In addition, the company provides treatment of pain, such as fever, migraine, joint pain, headache, and backpain under the AxPain brand. Kotra Industries Berhad was founded in 1982 and is headquartered in Malacca, Malaysia. The company is a subsidiary of Piong Nam Kim Holdings Sdn. Bhd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0002.KLSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
